mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.00066 |
1 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.00044 |
1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00041 |
1 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.00052 |
1 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.00039 |
1 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.00035 |
1 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.00031 |
1 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
0.00033 |
1 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00027 |
1 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.00024 |
1 |